Opko Health (OPK) Short-term Investments (2011 - 2018)

Opko Health's (OPK) quarterly Short-term Investments came in at $26.3 million in Q4 2018, up 68.31% on a QoQ basis from $15.6 million in Q2 2016.

Opko Health (OPK) Short-term Investments (2011 - 2018) Analysis & Trends

Opko Health (OPK) has 5 years of Short-term Investments data on file, last reported at $26.3 million in Q4 2018.

Quarterly Short-term Investments changed N/A year-over-year to $26.3 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $26.3 million (changed N/A YoY) and the FY2018 annual result came in at $26.3 million, changed N/A from the prior year.
Short-term Investments rose to $26.3 million in Q4 2018, from $15.6 million in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $26.3 million in Q4 2018 to a low of $15.6 million in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.44 Bn	209.37 Bn	8.34 Bn
2	Danaher	139.95 Bn	135.60 Bn	3.61 Bn
3	Idexx Laboratories	46.16 Bn	45.96 Bn	779.09 Mn
4	Agilent Technologies	39.67 Bn	37.87 Bn	990.00 Mn
5	Iqvia Holdings	39.29 Bn	37.21 Bn	1.44 Bn
6	Natera	38.61 Bn	37.51 Bn	696.04 Mn
7	Illumina	29.99 Bn	28.82 Bn	770.00 Mn
8	Mettler Toledo International	28.57 Bn	28.51 Bn	650.22 Mn
9	Quest Diagnostics	26.17 Bn	25.55 Bn	1.03 Bn
10	Opko Health	1.01 Bn	712.28 Mn	80.02 Mn

Download Data